Conference Coverage

Study highlights need to investigate psoriasis treatment outcomes in skin of color patients

Publish date: March 9, 2018

 

REPORTING FROM ODAC 2018

dermnews@frontlinemedcom.com

SOURCE: Kaufman B et al. ODAC 2018

Pages

Recommended Reading

Online psoriasis consultations shown equivalent to office visits
MDedge Dermatology
Phase 3 trials show halobetasol/tazarotene lotion works for psoriasis
MDedge Dermatology
Do Psoriasis Patients Engage In Vigorous Physical Activity?
MDedge Dermatology
Concurrent Anticytokine Biologics for the Management of Severe Hidradenitis Suppurativa: Are They Safe and Effective?
MDedge Dermatology
Pushing the Limits: Developing a New Standard of Care for Psoriasis
MDedge Dermatology
Emerging Therapies In Psoriasis: A Systematic Review
MDedge Dermatology
Current Guidelines for Psoriasis Treatment: A Work in Progress
MDedge Dermatology
Biologics and Systemic Therapies for Psoriasis: Treat the Patient, Not the Disease
MDedge Dermatology
Pediatric Psoriasis: An Interview With Nanette B. Silverberg, MD
MDedge Dermatology
Xeljanz: FDA panel recommends ulcerative colitis indication
MDedge Dermatology